Antisense oligonucleotide (ASO) technology has accelerated drug discovery in the last few decades with several ASO-based ...

It is important to stress that the oligonucleotide probes are designed using the same set of composition rules regardless of the organism or set of RNAs interrogated. This consistency of design ...

Delray Beach, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 ...

Oligonucleotide API MarketThe global oligonucleotide API market is poised to grow from USD 2.81 billion in 2024 to USD 4.84 billion by 2034, expanding at a CAGR of 5.60%. The increasing need for ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Oligonucleotide Synthesis ...

Oligonucleotide therapeutics are becoming increasingly popular, with scientists developing treatments for rare diseases, cancer, and respiratory disorders. To ensure their quality, researchers must ...

A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

Delray Beach, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...